A20 Negatively Regulates T Cell Receptor Signaling to NF-κB by Cleaving Malt1 Ubiquitin Chains
The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Abstract
The Carma1-Bcl10-Malt1 signaling module bridges TCR signaling to the canonical IκB kinase (IKK)/NF-κB pathway. Covalent attachment of regulatory ubiquitin chains to Malt1 paracaspase directs TCR signaling to IKK activation. Further, the ubiquitin-editing enzyme A20 was recently suggested to suppress T cell activation, but molecular targets for A20 remain elusive. In this paper, we show that A20 regulates the strength and duration of the IKK/NF-κB response upon TCR/CD28 costimulation. By catalyzing the removal of K63-linked ubiquitin chains from Malt1, A20 prevents sustained interaction between ubiquitinated Malt1 and the IKK complex and thus serves as a negative regulator of inducible IKK activity. Upon T cell stimulation, A20 is rapidly removed and paracaspase activity of Malt1 has been suggested to cleave A20. Using antagonistic peptides or reconstitution of Malt1−/− T cells, we show that Malt1 paracaspase activity is required for A20 cleavage and optimal IL-2 production, but dispensable for initial IKK/NF-κB signaling in CD4+ T cells. However, proteasomal inhibition impairs A20 degradation and impedes TCR/CD28-induced IKK activation. Taken together, A20 functions as a Malt1 deubiquitinating enzyme and proteasomal degradation and de novo synthesis of A20 contributes to balance TCR/CD28-induced IKK/NF-κB signaling.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“UBASH3A (rank 10), TNFAIP3, and its partner TNIP1 (rank 13 and 24, respectively) inhibit TCR-induced NFkB signaling, a critical survival and growth signal for activated CD8+ T cells (Düwel et al., 2009; Ge et al., 2017).”
From Genome-wide CRISPR Screens in Primary Human T Cells Reveal Key Regulators of Immune Function (2018) · cites this paper as Düwel et al., 2009
Citations
Cites
Shared Principles in NF-κB Signaling
Hayden, M. S., & Ghosh, S. (2008) · Cell · doi:10.1016/j.cell.2008.01.020 · Cited by 4,494
De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-κB signalling
Wertz, I. E., O'Rourke, K. M., Zhou, H., Eby, M., Aravind, L., Seshagiri, S., Wu, P., Wiesmann, C., Baker, R., Boone, D. L., et al. (2004) · Nature · doi:10.1038/nature02794 · Cited by 1,856
PKC-θ is required for TCR-induced NF-κB activation in mature but not immature T lymphocytes
Sun, Z., Arendt, C. W., Ellmeier, W., Schaeffer, E. M., Sunshine, M. J., Gandhi, L., Annes, J., Petrzilka, D., Kupfer, A., Schwartzberg, P. L., et al. (2000) · Nature · doi:10.1038/35006090 · Cited by 892 · cited 1×
“In T cells, activation of the atypical protein kinase C (PKC) has been shown to provide a critical link between TCR/ CD28 proximal signaling events and the NF- B pathway (4).”
Sun, L., Deng, L., Ea, C.-K., Xia, Z.-P., & Chen, Z. J. (2004) · Molecular Cell · doi:10.1016/s1097-2765(04)00236-9 · Cited by 699 · cited 2×
“Further, IKK ubiquitination has been implicated in IKK activation after T cell stimulation (17, 20) and might there-”
Ubiquitin Chain Editing Revealed by Polyubiquitin Linkage-Specific Antibodies
Newton, K., Matsumoto, M. L., Wertz, I. E., Kirkpatrick, D. S., Lill, J. R., Tan, J., Dugger, D., Gordon, N., Sidhu, S. S., Fellouse, F. A., et al. (2008) · Cell · doi:10.1016/j.cell.2008.07.039 · Cited by 555
Ruland, J., Duncan, G. S., Elia, A., del Barco Barrantes, I., Nguyen, L., Plyte, S., Millar, D. G., Bouchard, D., Wakeham, A., Ohashi, P. S., et al. (2001) · Cell · doi:10.1016/s0092-8674(01)00189-1 · Cited by 553
Self-citationBcl10 activates the NF-κB pathway through ubiquitination of NEMO
Zhou, H., Wertz, I., O'Rourke, K., Ultsch, M., Seshagiri, S., Eby, M., Xiao, W., & Dixit, V. M. (2004) · Nature · doi:10.1038/nature02273 · Cited by 527 · cited 2×
“Further, IKK ubiquitination has been implicated in IKK activation after T cell stimulation (17, 20) and might there-”
Coornaert, B., Baens, M., Heyninck, K., Bekaert, T., Haegman, M., Staal, J., Sun, L., Chen, Z. J., Marynen, P., & Beyaert, R. (2008) · Nature Immunology · doi:10.1038/ni1561 · Cited by 434 · cited 8×
“Interestingly, two recent reports have shown that Malt1 paracaspase activity is required for optimal IL-2 production and it was suggested that the paracaspase-dependent cleavage of A20 could be one explanation for this result (28, 29).”
Self-citationRequirement for Caspase-8 in NF-κB Activation by Antigen Receptor
Su, H., Bidère, N., Zheng, L., Cubre, A., Sakai, K., Dale, J., Salmena, L., Hakem, R., Straus, S., & Lenardo, M. (2005) · Science · doi:10.1126/science.1104765 · Cited by 429 · cited 1×
“In addition, association of PDK1 and Caspase8 to the PKC -CBM signaling module has been shown to facilitate TCR-induced NF- B activation (12, 13).”
Differential Requirement for Malt1 in T and B Cell Antigen Receptor Signaling
Ruland, J., Duncan, G. S., Wakeham, A., & Mak, T. W. (2003) · Immunity · doi:10.1016/s1074-7613(03)00293-0 · Cited by 390
Self-citation
Cited by
Genome-wide CRISPR Screens in Primary Human T Cells Reveal Key Regulators of Immune Function
Shifrut, E., Carnevale, J., Tobin, V., Roth, T. L., Woo, J. M., Bui, C. T., Li, P. J., Diolaiti, M. E., Ashworth, A., & Marson, A. (2018) · Cell · doi:10.1016/j.cell.2018.10.024 · Cited by 573
A20: linking a complex regulator of ubiquitylation to immunity and human disease
Ma, A., & Malynn, B. A. (2012) · Nature Reviews Immunology · doi:10.1038/nri3313 · Cited by 548
A20 in inflammation and autoimmunity
Catrysse, L., Vereecke, L., Beyaert, R., & van Loo, G. (2014) · Trends in Immunology · doi:10.1016/j.it.2013.10.005 · Cited by 493
Ubiquitin signaling in immune responses
Hu, H., & Sun, S.-C. (2016) · Cell Research · doi:10.1038/cr.2016.40 · Cited by 485
Ubiquitylation in apoptosis: a post-translational modification at the edge of life and death
Vucic, D., Dixit, V. M., & Wertz, I. E. (2011) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3143 · Cited by 444
Return to homeostasis: downregulation of NF-κB responses
Ruland, J. (2011) · Nature Immunology · doi:10.1038/ni.2055 · Cited by 322
Self-citationMatmati, M., Jacques, P., Maelfait, J., Verheugen, E., Kool, M., Sze, M., Geboes, L., Louagie, E., Guire, C. M., Vereecke, L., et al. (2011) · Nature Genetics · doi:10.1038/ng.874 · Cited by 290
CYLD, A20 and OTULIN deubiquitinases in NF-κB signaling and cell death: so similar, yet so different
Lork, M., Verhelst, K., & Beyaert, R. (2017) · Cell Death & Differentiation · doi:10.1038/cdd.2017.46 · Cited by 282
Jeltsch, K. M., Hu, D., Brenner, S., Zöller, J., Heinz, G. A., Nagel, D., Vogel, K. U., Rehage, N., Warth, S. C., Edelmann, S. L., et al. (2014) · Nature Immunology · doi:10.1038/ni.3008 · Cited by 274
“As a reporter-gene, the human ICOS CDS was cloned into the pCR8/GW/TOPO vector (Life Technologies) and sequences of the 3′ UTRs of cRel (1-537), Ctla4 (1-1090), Nfkbid (1-559), Nfkbiz (1-1333), Il6 (1-403), Irf4 (1-3260) and Tnf (490-749; the CDE260 element) were ligated downstream.”
MethodSelf-citationThe Ubiquitin Modifying Enzyme A20 Restricts B Cell Survival and Prevents Autoimmunity
Tavares, R. M., Turer, E. E., Liu, C. L., Advincula, R., Scapini, P., Rhee, L., Barrera, J., Lowell, C. A., Utz, P. J., Malynn, B. A., et al. (2010) · Immunity · doi:10.1016/j.immuni.2010.07.017 · Cited by 271
“A20 has also been reported to deubiquitinate MALT-1 to restrict TCR signals (Düwel et al., 2009).”
BackgroundDeubiquitinases in the regulation of NF-κB signaling
Harhaj, E. W., & Dixit, V. M. (2011) · Cell Research · doi:10.1038/cr.2010.166 · Cited by 261
Regulation of NF‐κB by deubiquitinases
Harhaj, E. W., & Dixit, V. M. (2012) · Immunological Reviews · doi:10.1111/j.1600-065x.2012.01100.x · Cited by 260
“A20 targets MALT1 in the TCR and BCR pathways by removing K63-linked polyubiquitin chains in an OTU domain-dependent manner (108) (Fig.”
BackgroundA20: from ubiquitin editing to tumour suppression
Hymowitz, S. G., & Wertz, I. E. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2775 · Cited by 247
Expanding role of ubiquitination in NF-κB signaling
Liu, S., & Chen, Z. J. (2011) · Cell Research · doi:10.1038/cr.2010.170 · Cited by 241
Hailfinger, S., Nogai, H., Pelzer, C., Jaworski, M., Cabalzar, K., Charton, J.-E., Guzzardi, M., Décaillet, C., Grau, M., Dörken, B., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1105020108 · Cited by 240
“Interestingly, Malt1 inhibition has no influence on IKK-dependent IκBα phosphorylation (13, 16), suggesting that another, IKK-independent mechanism of NF-κB activation must contribute to canonical NF-κB activation in lymphocytes.”
BackgroundAntigen Receptor Signaling to NF- B via CARMA1, BCL10, and MALT1
Thome, M., Charton, J. E., Pelzer, C., & Hailfinger, S. (2010) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a003004 · Cited by 241
“Surprisingly however, treatment with a cell-permeable MALT1 protease inhibitor did not affect IkB phosphorylation by the IKK complex (Rebeaud et al. 2008; Duwel et al. 2009).”
BackgroundInfluentialNagel, D., Spranger, S., Vincendeau, M., Grau, M., Raffegerst, S., Kloo, B., Hlahla, D., Neuenschwander, M., Peter von Kries, J., Hadian, K., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.11.002 · Cited by 233
Self-citationExpression, biological activities and mechanisms of action of A20 (TNFAIP3)
Verstrepen, L., Verhelst, K., van Loo, G., Carpentier, I., Ley, S. C., & Beyaert, R. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.06.044 · Cited by 219
Regulation of NF-κB signaling by the A20 deubiquitinase
Shembade, N., & Harhaj, E. W. (2012) · Cellular & Molecular Immunology · doi:10.1038/cmi.2011.59 · Cited by 211
Selective Autophagy of the Adaptor Protein Bcl10 Modulates T Cell Receptor Activation of NF-κB
Paul, S., Kashyap, A. K., Jia, W., He, Y.-W., & Schaefer, B. C. (2012) · Immunity · doi:10.1016/j.immuni.2012.04.008 · Cited by 206
“Previous studies have suggested that p62 interacts with Malt1 and that Malt1 can be K63 polyubiquitinated in TCR-dependent manner (Düwel et al., 2009; Martin et al., 2006).”
BackgroundCARD–BCL-10–MALT1 signalling in protective and pathological immunity
Ruland, J., & Hartjes, L. (2019) · Nature Reviews Immunology · doi:10.1038/s41577-018-0087-2 · Cited by 196
Self-citationInhibitory feedback control of NF-κB signalling in health and disease
Prescott, J. A., Mitchell, J. P., & Cook, S. J. (2021) · Biochemical Journal · doi:10.1042/bcj20210139 · Cited by 187
Regulation of proteolysis by human deubiquitinating enzymes
Eletr, Z. M., & Wilkinson, K. D. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2013.06.027 · Cited by 183
Das, T., Chen, Z., Hendriks, R. W., & Kool, M. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00104 · Cited by 165
Malt1 protease inactivation efficiently dampens immune responses but causes spontaneous autoimmunity
Jaworski, M., Marsland, B. J., Gehrig, J., Held, W., Favre, S., Luther, S. A., Perroud, M., Golshayan, D., Gaide, O., & Thome, M. (2014) · The EMBO Journal · doi:10.15252/embj.201488987 · Cited by 146
“These findings are consistent with previous studies using the Malt1 tetrapeptide inhibitor z-VRPR-fmk, which does not impair IKK activation (Duwel et al , 2009; Hailfinger et al , 2011).”
Kloo, B., Nagel, D., Pfeifer, M., Grau, M., Düwel, M., Vincendeau, M., Dörken, B., Lenz, P., Lenz, G., & Krappmann, D. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1008969108 · Cited by 144
Self-citationA20 at the Crossroads of Cell Death, Inflammation, and Autoimmunity
Martens, A., & Loo, G. (2019) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a036418 · Cited by 150
“Proteasomal degradation of A20, 6 Cite this article as Cold Spring Harb Perspect Biol 2020;12:a036418 as well as its cleavage by the paracaspase MALT1, contribute to the down-regulation of A20 following TCR stimulation (Coornaert et al. 2008; Duwel et al. 2009).”
BackgroundTNFAIP3 promotes survival of CD4 T cells by restricting MTOR and promoting autophagy
Matsuzawa, Y., Oshima, S., Takahara, M., Maeyashiki, C., Nemoto, Y., Kobayashi, M., Nibe, Y., Nozaki, K., Nagaishi, T., Okamoto, R., et al. (2015) · Autophagy · doi:10.1080/15548627.2015.1055439 · Cited by 136
“TNFAIP3 has also been reported to deubiquitinate MALT1 and restrict TCR signals.(23) In mice in which TNFAIP3 was specifically deleted in mature conventional T cells, Tnfaip3-deficient CD8 T cells exhibit increased sensitivity to antigen stimulation, as indicated by the increased production of IL2 and IFNG.”
BackgroundUbiquitin enzymes in the regulation of immune responses
Ebner, P., Versteeg, G. A., & Ikeda, F. (2017) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409238.2017.1325829 · Cited by 154
K63 ubiquitination in immune signaling
Madiraju, C., Novack, J. P., Reed, J. C., & Matsuzawa, S. (2022) · Trends in Immunology · doi:10.1016/j.it.2021.12.005 · Cited by 144
“proteasomal degradation to restore TCR/CD28-induced IKK activation [119].”
BackgroundA new look at T cell receptor signaling to nuclear factor-κB
Paul, S., & Schaefer, B. C. (2013) · Trends in Immunology · doi:10.1016/j.it.2013.02.002 · Cited by 126
Systems‐wide analysis of BCR signalosomes and downstream phosphorylation and ubiquitylation
Satpathy, S., Wagner, S. A., Beli, P., Gupta, R., Kristiansen, T. A., Malinova, D., Francavilla, C., Tolar, P., Bishop, G. A., Hostager, B. S., et al. (2015) · Molecular Systems Biology · doi:10.15252/msb.20145880 · Cited by 124
Giordano, M., Roncagalli, R., Bourdely, P., Chasson, L., Buferne, M., Yamasaki, S., Beyaert, R., van Loo, G., Auphan-Anezin, N., Schmitt-Verhulst, A.-M., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1406259111 · Cited by 122
Naylor, T. L., Tang, H., Ratsch, B. A., Enns, A., Loo, A., Chen, L., Lenz, P., Waters, N. J., Schuler, W., Dörken, B., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-2525 · Cited by 119
“In addition, we genetically confirmed that PKCb is the critical isoform, as shRNA-mediated knockdown of PKCb was selectively toxic to CD79-mutated cell lines.”
InfluentialShi, D., & Grossman, S. R. (2010) · Cancer Biology & Therapy · doi:10.4161/cbt.10.8.13417 · Cited by 132
The NF-κB regulator MALT1 determines the encephalitogenic potential of Th17 cells
Brüstle, A., Brenner, D., Knobbe, C. B., Lang, P. A., Virtanen, C., Hershenfield, B. M., Reardon, C., Lacher, S. M., Ruland, J., Ohashi, P. S., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci63528 · Cited by 115
“In contrast to MALT1’s scaffolding function, its protease activity is not crucial for IκBα degradation and acts downstream of IKK (41).”
InfluentialSelf-citationThe paracaspase MALT1: biological function and potential for therapeutic inhibition
Jaworski, M., & Thome, M. (2015) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-015-2059-z · Cited by 112
“A20 can negatively regulate IKK-dependent NF-jB activation by deubiquitination of MALT1 [53], and A20 levels decrease shortly after T-cell stimulation [53].”
BackgroundRegulation of NF-κB signaling by caspases and MALT1 paracaspase
Staal, J., Bekaert, T., & Beyaert, R. (2010) · Cell Research · doi:10.1038/cr.2010.168 · Cited by 114
The protease activity of the paracaspase MALT1 is controlled by monoubiquitination
Pelzer, C., Cabalzar, K., Wolf, A., Gonzalez, M., Lenz, G., & Thome, M. (2013) · Nature Immunology · doi:10.1038/ni.2540 · Cited by 105
Alternative splicing of MALT1 controls signalling and activation of CD4+ T cells
Meininger, I., Griesbach, R. A., Hu, D., Gehring, T., Seeholzer, T., Bertossi, A., Kranich, J., Oeckinghaus, A., Eitelhuber, A. C., Greczmiel, U., et al. (2016) · Nature Communications · doi:10.1038/ncomms11292 · Cited by 103
Self-citationMALT lymphoma: many roads lead to nuclear factor-κb activation
Du, M. (2011) · Histopathology · doi:10.1111/j.1365-2559.2010.03699.x · Cited by 104
The Ubiquitin–Proteasome System and Cardiovascular Disease
Powell, S. R., Herrmann, J., Lerman, A., Patterson, C., & Wang, X. (2012) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-397863-9.00009-2 · Cited by 110
MALT lymphoma: A paradigm of NF-κB dysregulation
Du, M. (2016) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2016.07.003 · Cited by 106
MALT1 Protease Activity Is Required for Innate and Adaptive Immune Responses
Yu, J. W., Hoffman, S., Beal, A. M., Dykon, A., Ringenberg, M. A., Hughes, A. C., Dare, L. C., Anderson, A. D., Finger, J. N., Kasparcova, V., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0127083 · Cited by 93
Holding All the CARDs: How MALT1 Controls CARMA/CARD-Dependent Signaling
Juilland, M., & Thome, M. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01927 · Cited by 87
“It has been proposed that A20 negatively regulates the scaffolding function of MALT1 by removing the MALT1 polyubiquitination (60), however this function of A20 does not seem to be affected by its cleavage, since MALT1 inhibitors do not affect IKK-mediated NF-κB activation.”
BackgroundStructural Analysis of Phenothiazine Derivatives as Allosteric Inhibitors of the MALT1 Paracaspase
Schlauderer, F., Lammens, K., Nagel, D., Vincendeau, M., Eitelhuber, A. C., Verhelst, S. H. L., Kling, D., Chruściel, A., Ruland, J., Krappmann, D., et al. (2013) · Angewandte Chemie International Edition · doi:10.1002/anie.201304290 · Cited by 86
Self-citationNegative regulation of NF-κB and its involvement in rheumatoid arthritis
Loo, G., & Beyaert, R. (2011) · Arthritis Research & Therapy · doi:10.1186/ar3324 · Cited by 85
“A20 is believed to inhibit NF-κB function by deubiquitinating specifi c NF-κB signalling molecules, such as RIP1, RIP2, TRAF6 and MALT1, which disrupts specifi c protein–protein interactions [38-41] (Figure 1).”
Mechanisms of Regulated and Dysregulated CARD11 Signaling in Adaptive Immunity and Disease
Bedsaul-Fryer, J. R., Carter, N. M., Deibel, K. E., Hutcherson, S. M., Jones, T. A., Wang, Z., Yang, C., Yang, Y., & Pomerantz, J. L. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02105 · Cited by 92
“MALT1 cleaves the inhibitory deubiquitinase A20 (41, 42) to limit its removal of polyubiquitinylated MALT1, thereby extending the time-course of NF-κB activation.”
BackgroundTargeting ubiquitin signaling for cancer immunotherapy
Zhou, X., & Sun, S. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00421-2 · Cited by 100
Modulation of RNA splicing enhances response to BCL2 inhibition in leukemia
Wang, E., Pineda, J. M. B., Kim, W. J., Chen, S., Bourcier, J., Stahl, M. F., Hogg, S. J., Bewersdorf, J. P., Han, C., Singer, M., et al. (2022) · Cancer Cell · doi:10.1016/j.ccell.2022.12.002 · Cited by 97
Afonina, I. S., Elton, L., Carpentier, I., & Beyaert, R. (2015) · FEBS Journal · doi:10.1111/febs.13325 · Cited by 84
Guire, C. M., Elton, L., Wieghofer, P., Staal, J., Voet, S., Demeyer, A., Nagel, D., Krappmann, D., Prinz, M., Beyaert, R., et al. (2014) · Journal of Neuroinflammation · doi:10.1186/1742-2094-11-124 · Cited by 84
“In contrast to MALT1’s scaffolding function, its protease activity is not crucial for IKK activation [8], but supports specific TCR-induced gene expression by inactivating negative regulators such”
BackgroundResultSelf-citationDephosphorylation of Carma1 by PP2A negatively regulates T‐cell activation
Eitelhuber, A. C., Warth, S. C., Schimmack, G., Düwel, M., Hadian, K., Demski, K., Beisker, W., Shinohara, H., Kurosaki, T., Heissmeyer, V., et al. (2010) · The EMBO Journal · doi:10.1038/emboj.2010.331 · Cited by 89
“NF-kB EMSA were performed essentially as described previously (Duwel et al, 2009).”
BackgroundMethodSelf-citationFernández‐Jiménez, N., Castellanos–Rubio, A., Plaza‐Izurieta, L., Irastorza, I., Elcoroaristizabal, X., Jauregi‐Miguel, A., López-Euba, T., Tutau, C., de Pancorbo, M. M., Vitoria, J. C., et al. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt520 · Cited by 83
Lymphocyte signaling and activation by the CARMA1-BCL10-MALT1 signalosome
Meininger, I., & Krappmann, D. (2016) · Biological Chemistry · doi:10.1515/hsz-2016-0216 · Cited by 81
Self-citationSantolla, M. F., Lappano, R., Cirillo, F., Rigiracciolo, D. C., Sebastiani, A., Abonante, S., Tassone, P., Tagliaferri, P., Martino, M. T. D., Maggiolini, M., et al. (2018) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-018-0767-6 · Cited by 75
“In this vein, it was demonstrated that A20 inhibits the activity of the nuclear factor kappa B (NF-kB) [18], which is largely involved in the development of many types of tumors [19, 20].”
BackgroundQuancard, J., Klein, T., Fung, S.-Y., Renatus, M., Hughes, N., Israël, L., Priatel, J. J., Kang, S., Blank, M. A., Viner, R. I., et al. (2019) · Nature Chemical Biology · doi:10.1038/s41589-018-0222-1 · Cited by 72
The function and regulation of OTU deubiquitinases
Du, J., Fu, L., Sui, Y., & Zhang, L. (2019) · Frontiers of Medicine · doi:10.1007/s11684-019-0734-4 · Cited by 85
B-cell receptor–driven MALT1 activity regulates MYC signaling in mantle cell lymphoma
Dai, B., Grau, M., Juilland, M., Klener, P., Höring, E., Molinský, J., Schimmack, G., Aukema, S., Hoster, E., Vogt, N., et al. (2016) · Blood · doi:10.1182/blood-2016-05-718775 · Cited by 75
Self-citationRoles of the NF-κB Pathway in B-Lymphocyte Biology
Sasaki, Y., & Iwaï, K. (2015) · Current topics in microbiology and immunology · doi:10.1007/82_2015_479 · Cited by 91
Regulators of A20 (TNFAIP3): new drug-able targets in inflammation
Momtazi, G., Lambrecht, B. N., Naranjo, J. R., & Schock, B. C. (2018) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00335.2018 · Cited by 88
“In T and B cells, antigen receptor stimulation results in the site-specific cleavage of A20 by the paracaspase MALT1, leading to the eventual disruption of its NF- B inhibitory potential (25, 33).”
BackgroundCutting Edge: TCR Ligation Triggers Digital Activation of NF-κB
Kingeter, L. M., Paul, S., Maynard, S. K., Cartwright, N. G., & Schaefer, B. C. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1001051 · Cited by 67
MALT lymphoma: Genetic abnormalities, immunological stimulation and molecular mechanism
Du, M. (2016) · Best Practice & Research Clinical Haematology · doi:10.1016/j.beha.2016.09.002 · Cited by 68
“Among these, A20, CYLD and RelB are NF-κB negative regulators [49-53], and constitutive activation of MALT1 by chromosome translocation may eliminate these negative regulators and cause relentless activation of the canonical NF-κB pathway.”
BackgroundJahan, A. S., Biquand, É., Muñoz-Moreno, R., Quang, A. L., Mok, C. K. P., Wong, H. H., Teo, Q. W., Valkenburg, S. A., Chin, A. W. H., Poon, L. L. M., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.01.015 · Cited by 74
Paracaspase MALT1 deficiency protects mice from autoimmune-mediated demyelination
Mc Guire, C., Wieghofer, P., Elton, L., Muylaert, D., Prinz, M., Beyaert, R., & van Loo, G. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1201351 · Cited by 67
The Ubiquitin System in Immune Regulation
Park, Y., Jin, H., Aki, D., Lee, J., & Liu, Y. (2014) · Advances in immunology · doi:10.1016/b978-0-12-800147-9.00002-9 · Cited by 77
“Interestingly, A20 also targets MALT1 for disrupting the sustained interaction between MALT1 and IKK complex upon TCR stimulation by removing K63-linked polyubiquitin chains, leading to the termination of IKK activity (Duwel et al., 2009).”
NF-κB Activation in Lymphoid Malignancies: Genetics, Signaling, and Targeted Therapy
Grondona, P., Bucher, P., Schulze‐Osthoff, K., Hailfinger, S., & Schmitt, A. (2018) · Biomedicines · doi:10.3390/biomedicines6020038 · Cited by 76
“Additionally, proteolytic inactivation of the deubiquitinating enzyme A20, which removes K63-linked polyubiquitin chains from key signaling mediators, such as TRAF6, IKKγ, and MALT1, and thus negatively regulates NF-κB activation, sustains maximum NF-κB induction (Figure 3) [121,127].”
BackgroundPark, Y., Jin, H., & Liu, Y. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1221925110 · Cited by 63
“Proc Natl Acad Sci USA 105(8):3023–3028.”
BackgroundTumor suppressor TNFAIP3 (A20) is frequently deleted in Sézary syndrome
Braun, F., Grabarczyk, P., Möbs, M., Braun, F., Eberle, J., Beyer, M., Sterry, W., Busse, F., Schröder, J., Delin, M., et al. (2011) · Leukemia · doi:10.1038/leu.2011.101 · Cited by 58
The Many Roles of Ubiquitin in NF-κB Signaling
Courtois, G., & Fauvarque, M. (2018) · Biomedicines · doi:10.3390/biomedicines6020043 · Cited by 68
“A20 hydrolyzes K63-linked chains on MALT1 to shut-off NF-κB activation [230].”
BackgroundA20: a master regulator of arthritis
Wu, Y., He, X., Huang, N., Yu, J., & Shao, B. (2020) · Arthritis Research & Therapy · doi:10.1186/s13075-020-02281-1 · Cited by 58
“For example, Human A20 is cleaved by MALT1 at Ala439, while mouse A20 is cleaved at the site between ZnF3 and ZnF4.”
BackgroundInfluentialRecent Advances in the Genetic of MALT Lymphomas
Rodríguez‐Sevilla, J. J., & Salar, A. (2021) · Cancers · doi:10.3390/cancers14010176 · Cited by 58
Brechmann, M., Mock, T., Nickles, D., Kießling, M. K., Weit, N., Breuer, R. J., Müller, W. W., Wabnitz, G. H., Frey, F., Nicolay, J. P., et al. (2012) · Immunity · doi:10.1016/j.immuni.2012.07.014 · Cited by 56
Gavali, S., Liu, J., Li, X., & Paolino, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910800 · Cited by 59
Abbasi, A., Forsberg, K., & Bischof, F. (2015) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2015.00021 · Cited by 56
“In addition, A20 negatively regulates TCR-induced activation of NF-κB by deubiquitinating Malt1 (Düwel et al., 2009).”
BackgroundRoles of A20 in autoimmune diseases
Zhang, M., Peng, L., Wang, Y., Wang, J., Liu, J., Liu, M., Hu, J., Song, B., & Yang, H. (2015) · Immunologic Research · doi:10.1007/s12026-015-8677-6 · Cited by 55
“Tavares et al. [25] showed that A20 protein was significantly induced by CD40 engagement in A20-sufficient B cells, whereas no A20 expression was observed in A20-deficient B cells, and A20-deficient B cells indicated up-regulated and prolonged canonical NFjB signaling evaluated by IjBa phosphorylation in response to a…”
BackgroundInfluentialLamason, R. L., Kupfer, A., & Pomerantz, J. L. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.11.007 · Cited by 51
“Downstream of CARD11, A20 appears to dampen pathway output after signaling has begun by removing the K63-linked ubiquitin chains on MALT1 that contribute to the association between MALT1 and the IKK complex (Düwel et al., 2009).”
Usp12 stabilizes the T-cell receptor complex at the cell surface during signaling
Jahan, A. S., Lestra, M., Swee, L. K., Fan, Y., Lamers, M. M., Tafesse, F., Theile, C. S., Spooner, E., Bruzzone, R., Ploegh, H. L., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1521763113 · Cited by 58
“USP9X, and A20, have been described previously (6, 28, 35, 55, 56).”
BackgroundInfluentialThe Complexity of Being A20: From Biological Functions to Genetic Associations
Karri, U., Harasimowicz, M., Tumba, M. C., & Schwartz, D. M. (2024) · Journal of Clinical Immunology · doi:10.1007/s10875-024-01681-1 · Cited by 52
USP38 critically promotes asthmatic pathogenesis by stabilizing JunB protein
Chen, S., Yun, F., Yao, Y., Cao, M., Zhang, Y., Wang, J., Song, X., & Qian, Y. (2018) · The Journal of Experimental Medicine · doi:10.1084/jem.20172026 · Cited by 52
“, 2004), T cell activation (Düwel et al., 2009; Naik et al., 2014; Hu et al., 2016), and T cell differentiations (Liu et al.”
MALT1 Protease: A New Therapeutic Target in B Lymphoma and Beyond?
McAllister‐Lucas, L. M., Baens, M., & Lucas, P. C. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-0467 · Cited by 47
“IKK-γ subunit and even MALT1 itself (37,39,40).”
Self-citationKlei, L. R., Hu, D. G., Panek, R., Alfano, D. N., Bridwell, R. E., Bailey, K. M., Oravecz-Wilson, K. I., Concel, V. J., Hess, E. M., Beek, M. V., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.08.080 · Cited by 47
“…RelB, CYLD, and A20, are negative regulators of canonical NF-κB signaling, operating downstream from the IKK complex (Brummelkamp et al., 2003; Duwel et al., 2009; Hailfinger et al., 2011; Stilo et al., 2008; Sun, 2010), so that MALT1-dependent cleavage and destruction of these important…”
BackgroundOn to the road to degradation: atherosclerosis and the proteasome
Herrmann, S. M., Lerman, L. O., & Lerman, A. (2009) · Cardiovascular Research · doi:10.1093/cvr/cvp333 · Cited by 60
Activity-Based Probes for Detection of Active MALT1 Paracaspase in Immune Cells and Lymphomas
Eitelhuber, A. C., Vosyka, O., Nagel, D., Bognar, M., Lenze, D., Lammens, K., Schlauderer, F., Hlahla, D., Hopfner, K., Lenz, G., et al. (2014) · Chemistry & Biology · doi:10.1016/j.chembiol.2014.10.021 · Cited by 43
Self-citationTranscriptional and epigenetic regulation of immune tolerance: roles of the NF-κB family members
Zhang, L., Xiao, X., Arnold, P. R., & Li, X. C. (2019) · Cellular and Molecular Immunology · doi:10.1038/s41423-019-0202-8 · Cited by 46
Shen, W., Du, R., Li, J., Luo, X., Zhao, S., Chang, A., Zhou, W., Gao, R., Luo, D., Wang, J., et al. (2016) · Signal Transduction and Targeted Therapy · doi:10.1038/sigtrans.2016.13 · Cited by 47
The dual roles of A20 in cancer
Shi, Y., Wang, X., Wang, J., Wang, X., Zhou, H., & Zhang, L. (2021) · Cancer Letters · doi:10.1016/j.canlet.2021.04.017 · Cited by 46
Urbano, P. C. M., Aguirre‐Gamboa, R., Ashikov, A., van Heeswijk, B., Krippner‐Heidenreich, A., Tijssen, H. J., Li, Y., Azevedo, V. F., Smits, L. J. T., Hoentjen, F., et al. (2017) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2017.11.024 · Cited by 44
Luo, C., Zhang, R., Guo, R., Wu, L., Xue, T., He, Y., Jin, Y., Zhao, Y., Zhang, Z., Zhang, P., et al. (2025) · Immunity · doi:10.1016/j.immuni.2025.02.007 · Cited by 38
Scudiero, I., Vito, P., & Stilo, R. (2013) · Journal of Cellular Physiology · doi:10.1002/jcp.24543 · Cited by 40
“The importance of the ubiquitination events for the CBM-dependent activation of NF-kB is furthermore underlined by the fact that enzymatic deubiquitinases such as A20 significantly inhibit activation of NF-kB -mediated by the CBM complex (Stilo et al., 2008; Düwel et al., 2009).”
BackgroundNKT sublineage specification and survival requires the ubiquitin-modifying enzyme TNFAIP3/A20
Drennan, M. B., Govindarajan, S., Verheugen, E., Coquet, J. M., Staal, J., McGuire, C., Taghon, T., Leclercq, G., Beyaert, R., Loo, G., et al. (2016) · The Journal of Experimental Medicine · doi:10.1084/jem.20151065 · Cited by 40
“The rapid removal of A20 after TCR stimulation is therefore associated with elevated IKK activity and enhanced NF-κB signaling in activated T cells (Düwel et al., 2009).”
BackgroundResultZhao, H., Wang, L., Luo, H., Li, Q., & Zuo, X. (2017) · Rheumatology · doi:10.1093/rheumatology/kew508 · Cited by 43
Ubiquitination and phosphorylation of the CARD11-BCL10-MALT1 signalosome in T cells
Lork, M., Staal, J., & Beyaert, R. (2018) · Cellular Immunology · doi:10.1016/j.cellimm.2018.11.001 · Cited by 42
Function and targeting of MALT1 paracaspase in cancer
O’Neill, T. J., Tofaute, M. J., & Krappmann, D. (2023) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2023.102568 · Cited by 40
Self-citationLaletin, V., Bernard, P.-L., Silva, C. C. D., Guittard, G. C., & Nunès, J. A. (2023) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2022-005845 · Cited by 49
Li, D., Wang, L., Fan, Y., Song, L., Guo, C. H., Zhu, F., Zhang, L., & Shi, Y. (2012) · Journal of Clinical Immunology · doi:10.1007/s10875-012-9764-2 · Cited by 40
“Since A20 gene has a function in limiting activation of T cell by deubiquitinating Malt1 to disrupt T cell receptor signaling to NF-κB [9], its decreased expression may induce hyperactivation of T cell and the subsequent tissue damage occurring in susceptible organs of SLE patients.”
InfluentialA20 Restrains Thymic Regulatory T Cell Development
Fischer, J. C., Otten, V., Kober, M., Drees, C., Rosenbaum, M., Schmickl, M., Heidegger, S. M., Beyaert, R., Loo, G., Li, X. C., et al. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1602102 · Cited by 38
“In return, MALT1 also has a proteolytic activity, which can inactivate A20 (31, 32).”
BackgroundWeber, A., Elliott, P. R., Pinto-Fernández, A., Bonham, S., Kessler, B. M., Komander, D., Oualid, F. E., & Krappmann, D. (2017) · Cell chemical biology · doi:10.1016/j.chembiol.2017.08.006 · Cited by 41
“1 HA-SHARPIN Laboratory of Daniel Krappmann (Muller-Rischart et al., 2013) pEF FLAG-OTUB1 Laboratory of Kamyar Hadian N/A pEF FLAG-CYLD Laboratory of Daniel Krappmann N/A pEF FLAG-A20 Laboratory of Daniel Krappmann (Duwel et al., 2009) pEF FLAG-YOD1 Laboratory of Daniel Krappmann (Schimmack et al., 2017) pEF4 FLAG-UCH…”
BackgroundSelf-citationA patent review of MALT1 inhibitors (2013-present)
Hamp, I., O’Neill, T. J., Plettenburg, O., & Krappmann, D. (2021) · Expert Opinion on Therapeutic Patents · doi:10.1080/13543776.2021.1951703 · Cited by 35
“FMK binding to the catalytic cysteine-464 did not reduce NFκB activation in T cells [6,33,34,110], MLT-827 treatment moderately impaired NF-κB activation [63].”
BackgroundSelf-citationWei, F., Jiang, Z., Sun, H., Pu, J., Sun, Y., Wang, M., Tong, Q., Bi, Y., Ma, X., Gao, G. F., et al. (2019) · PLoS Pathogens · doi:10.1371/journal.ppat.1008062 · Cited by 41
Metadata
- Authors
- Düwel, M., Welteke, V., Oeckinghaus, A., Baens, M., Kloo, B., Ferch, U., Darnay, B. G., Ruland, J., Marynen, P., & Krappmann, D.
- Affiliations
- Helmholtz Munich (DE)
- Vlaams Instituut voor Biotechnologie (BE)
- TUM Klinikum (DE)
- The University of Texas MD Anderson Cancer Center (US)
- Corresponding author
- Welteke, Verena
- Oeckinghaus, Andrea
- Kloo, Bernhard
- Krappmann, Daniel
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2009-06
- Volume
- 182
- Issue
- 12
- Pages
- 7718-7728
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W1955888505
- Cited by
- 233
- References
- 40
- Citations by year
- 2026: 4 · 2025: 13 · 2024: 8 · 2023: 9 · 2022: 11 · 2021: 11 · 2020: 12 · 2019: 10 · 2018: 16 · 2017: 13 · 2016: 18 · 2015: 21 · 2014: 17 · 2013: 20 · 2012: 15
- FWCI
- 5.58
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Immunology (publishedVersion)
- PubMed (publishedVersion)
- mediaTUM (Technical University of Munich) (submittedVersion)
- Site cant be reached (submittedVersion)
- Funders
- Silence Therapeutics
- Genentech
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Keywords
- A20, MALT1, T cell receptor signaling, NF-κB, IKK activation, K63-linked ubiquitin, deubiquitination, paracaspase, CD28 costimulation, proteasomal degradation, IL-2 production, T cell activation
- MeSH terms
- Tumor Necrosis Factor alpha-Induced Protein 3, Mucosa-Associated Lymphoid Tissue Lymphoma Translocation 1 Protein, Cell Line, DNA-Binding Proteins, Enzyme Activation, Humans, Neoplasm Proteins, Nuclear Proteins, Protein Binding, Receptors, Antigen, T-Cell, Signal Transduction, Down-Regulation, NF-kappa B, Caspases, Ubiquitin, RNA, Small Interfering, Proteasome Endopeptidase Complex, Intracellular Signaling Peptides and Proteins, I-kappa B Kinase, CARD Signaling Adaptor Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.